Correction to: Nature Medicine https://doi.org/10.1038/s41591-025-03715-6, published online 27 May 2025. In the version of the article initially published, the far-right column of the lower panel in Fig. 2c was missing and has now been added, as seen in Fig. 1, below.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Anne Bertolini
Feasibility of multiomics tumor profiling for guiding treatment of melanoma - Nature Medicine
|
By Nora C Toussaint, Ximena Bonilla, Tarun Mehra, Francis Jacob, Rebekka Wegmann, Julien Mena, Sandra Goetze, Franziska Singer, Anne Bertolini, Michael Prummer, Rudolf Aebersold, Holger Moch, Michael Weller, Markus G. Manz, Niko Beerenwinkel, Christian Beisel, Bernd Bodenmiller, Mitchell Levesque, Viktor H. Koelzer, Reinhard Dummer, Parisa Rahimzadeh, Natalia Chicherova
|
Nature
Verified
Abstract There is limited evidence supporting the feasibility of using omics and functional technologies to inform treatment decisions. Here we present results from a cohort of 116 melanoma patients in the prospective, multicentric observational Tumor Profiler (TuPro) precision oncology project. Nine independent technologies, mostly at single-cell level, were used to analyze 126 patient samples, generating up to 500 Gb of data per sample (40,000 potential markers) within 4 weeks.
gExcite - A start-to-end framework for single-cell gene expression, hashing, and antibody analysis
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
scROSHI - robust supervised hierarchical identification of single cells
Abstract Identifying cell types based on expression profiles is a pillar of single cell analysis. Existing machine-learning methods identify predictive features from annotated training data, which are often not available in early-stage studies. This can lead to overfitting and inferior performance when applied to new data. To address these challenges we present scROSHI, which utilizes previously obtained cell type-specific gene sets and does not require training or the existence of annotated data.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Anne
Contact Anne, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack